APA (7th ed.) Citation

R, W., Z, M., M, E., SS, D., R, P., DV, M., . . . M, A. (2026). Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency. European journal of medicinal chemistry, 302(Pt 1), 118261. https://doi.org/10.1016/j.ejmech.2025.118261

Chicago Style (17th ed.) Citation

R, Waheed, et al. "Revisiting COX-2 Inhibitors for Alzheimer's Disease as Multitargeted Ligands: Development of 4-hydrazono-pyrazolidinediones with Tuned COX Selectivity Profile and Improved Cellular Potency." European Journal of Medicinal Chemistry 302, no. Pt 1 (2026): 118261. https://doi.org/10.1016/j.ejmech.2025.118261.

MLA (9th ed.) Citation

R, Waheed, et al. "Revisiting COX-2 Inhibitors for Alzheimer's Disease as Multitargeted Ligands: Development of 4-hydrazono-pyrazolidinediones with Tuned COX Selectivity Profile and Improved Cellular Potency." European Journal of Medicinal Chemistry, vol. 302, no. Pt 1, 2026, p. 118261, https://doi.org/10.1016/j.ejmech.2025.118261.